Reducing Aggression Among People With an Intellectual Disability
NCT03212092 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 137
Last updated 2021-03-09
Summary
The study is an randomised controlled trial (RCT) to test whether supplementation of vitamins, minerals and n-3 fatty acids may reduce aggressive behavior in people with intellectual disabilities.
Conditions
- Aggression
- Intellectual Disability
Interventions
- DIETARY_SUPPLEMENT
-
Multivitamin, mineral & n-3 FA
The 2 multi vitamin capsules with the two multi vitamin softgel capsules will be handed out once a day during a meal by the staff of the care organization. The compliance will be registered
- DIETARY_SUPPLEMENT
-
Placebo
The placebo of the multi vitamin capsules and the two multi vitamin softgel capsules will be handed out once a day during a meal by the staff of the care organization. The compliance will be registered
Sponsors & Collaborators
-
Leiden University Medical Center
lead OTHER
Principal Investigators
-
Erik Giltay, MD, PHD · Leiden University Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 39 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-15
- Primary Completion
- 2021-02-01
- Completion
- 2021-03-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Clinical Trial to Evaluate the Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children
NCT00770627 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Cohort Study of DHA in Neurodevelopmental Disorders
NCT05841927 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of a Nutritional Supplement on Mental Wellness in Adults
NCT06058364 ·Status: COMPLETED ·Phase: NA
-
Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children
NCT02248948 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Polyunsaturated Fatty Acids in Youth With ADHD
NCT03542643 ·Status: COMPLETED ·Phase: NA
-
Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD
NCT00382616 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHD
NCT01554462 ·Status: COMPLETED ·Phase: NA
-
Intervention With Omega-3 in Children With Attention Deficit Hyperactivity Disorder(ADHD)
NCT02986672 ·Status: COMPLETED ·Phase: NA
-
Developing Treatment, Treatment Validation and Treatment Scope in the Setting of an Autism Clinical Trial
NCT01260961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Omega-3 Supplementation on Child Behavior Problems
NCT02016079 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Omega-3/Omega-6 Fatty Acids in Pre-school Children at Risk for ADHD
NCT01795040 ·Status: UNKNOWN ·Phase: NA
-
Effects of Omega-3 Fatty Acids Supplementation on Brain and Behaviour in Healthy Children.
NCT02346773 ·Status: COMPLETED ·Phase: NA
-
The Correlation Between Blood omega3 and ADHD
NCT02391428 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Effects of DHA on Attention Deficit and Hyperactivity Disorder
NCT01796262 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit Hyperactivity Disorder in Children
NCT01807299 ·Status: COMPLETED ·Phase: NA
-
Effects of a High EPA Multinutrient Supplement on Negative Affect in Young Adults.
NCT04844034 ·Status: UNKNOWN ·Phase: NA
-
Omega-3 Supplementation and Behavior Problems
NCT02334098 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Docosahexaenoic Acid in the Treatment of Autism
NCT00577447 ·Status: COMPLETED ·Phase: NA
-
Intervening to Repair Cognitive and Behavioural Problems in Adults Exposed to Childhood Malnutrition
NCT04053218 ·Status: UNKNOWN ·Phase: PHASE3
-
Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms
NCT06698588 ·Status: RECRUITING ·Phase: NA
-
Effect of Long Chain Polyunsaturated Fatty Acids on Behavior and Cognition in Children With Attention Deficit Hyperactivity Disorder
NCT01055119 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Supplementation to Both Parent and Adolescent
NCT05893550 ·Status: UNKNOWN ·Phase: PHASE3
-
Omega-3 Fatty Acids and/or Multi-domain Intervention in the Prevention of Age-related Cognitive Decline
NCT00672685 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Fish Oil Supplementation on Cognition in MCI Patients and the Influence of the APOE4 Allele
NCT00746005 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia
NCT00621634 ·Status: WITHDRAWN ·Phase: PHASE2